Redhill Biopharma
RDHL
#10544
Rank
โ‚น0.36 B
Marketcap
โ‚น71.07
Share price
-4.86%
Change (1 day)
-70.22%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น66,330. In 2017 the company made an earnings per share (EPS) of -โ‚น2,36,893 a decrease over its 2016 EPS that were of -โ‚น2,08,465.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,36,89313.64%
2016-โ‚น2,08,4659.12%
2015-โ‚น1,91,03868.01%
2014-โ‚น1,13,708-25.93%
2013-โ‚น1,53,506

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น195.69-100.30%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น692.70-101.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น357.05-100.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น117.50-100.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น115.60-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel